| Net Cash Provided by (Used in) Operating Activities |
$110,200,000 |
USD |
-66% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$32,800,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$8,700,000 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
40,100,000 |
shares |
1.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$83,600,000 |
USD |
6.7% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$114,300,000 |
USD |
-32% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$339,200,000 |
USD |
22% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$431,500,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$66,200,000 |
USD |
-2.6% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$388,200,000 |
USD |
17% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$87,400,000 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$11,100,000 |
USD |
-20% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$12,300,000 |
USD |
-3.9% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$16,300,000 |
USD |
-5.2% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.08 |
pure |
103% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$5,400,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$21,200,000 |
USD |
141% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$11,200,000 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$209,300,000 |
USD |
40% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$17,500,000 |
USD |
59% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$9,800,000 |
USD |
26% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$222,500,000 |
USD |
3.8% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$92,300,000 |
USD |
-13% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$11,700,000 |
USD |
-24% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
EUR/shares |
0% |
Q3 2025 |
Q3 2025 |